Mirae Asset Global ETFs Holdings’s Greenwich LifeSciences GLSI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.8K	Sell	3,102 -30	-1%	-$730	﹤0.01%	2951
2026 Q1	$75.2K	Buy	3,132 +68	+2%	+$1.77K	﹤0.01%	2791
2025 Q4	$64.4K	Buy	3,064 +88	+3%	+$926	﹤0.01%	2859
2025 Q3	$29.6K	Sell	2,976 -506	-15%	-$5.71K	﹤0.01%	3022
2025 Q2	$31.6K	Sell	3,482 -156	-4%	-$1.48K	﹤0.01%	2939
2025 Q1	$34.7K	Buy	3,638 +156	+4%	+$1.89K	﹤0.01%	2908
2024 Q4	$39.1K	Buy	3,482 +152	+5%	+$2.04K	﹤0.01%	2939
2024 Q3	$47.9K	Buy	+3,330	New	+$49.3K	﹤0.01%	2921

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's GLSI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Greenwich LifeSciences (GLSI) stake by 0.96% in Q2 2026, selling an estimated $730 and leaving 3,102 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Mirae Asset Global ETFs Holdings first reported a position in GLSI in Q3 2024 and has held it in 8 quarters since. The position peaked at $75.2K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Mirae Asset Global ETFs Holdings held 3,102 shares of Greenwich LifeSciences worth $72.8K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 30 Greenwich LifeSciences shares in Q2 2026, an estimated $730.
Greenwich LifeSciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2951 holding.
Mirae Asset Global ETFs Holdings first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Greenwich LifeSciences position peaked at $75.2K in Q1 2026.
57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.